Laboratory of Protein Engineering, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven 5600 MB, The Netherlands.
ACS Sens. 2022 Dec 23;7(12):3800-3808. doi: 10.1021/acssensors.2c01726. Epub 2022 Nov 30.
Bioluminescent sensor proteins have recently gained popularity in both basic research and point-of-care diagnostics. Sensor proteins based on intramolecular complementation of split NanoLuc are particularly attractive because their intrinsic modular design enables for systematic tuning of sensor properties. Here we show how the sensitivity of these sensors can be enhanced by the introduction of catalytically inactive variants of the small SmBiT subunit (DarkBiTs) as intramolecular inhibitors. Starting from previously developed bioluminescent antibody sensor proteins (LUMABS), we developed single component, biomolecular switches with a strongly reduced background signal for the detection of three clinically relevant antibodies, anti-HIV1-p17, cetuximab (CTX), and an RSV neutralizing antibody (101F). These new dark-LUMABS sensors showed 5-13-fold increases in sensitivity which translated into lower limits of detection. The use of DarkBiTs as competitive intramolecular inhibitor domains is not limited to the LUMABS sensor family and might be used to boost the performance of other bioluminescent sensor proteins based on split luciferase complementation.
生物发光传感器蛋白最近在基础研究和即时诊断领域都受到了广泛关注。基于 NanoLuc 分割体分子内互补的传感器蛋白特别有吸引力,因为其内在的模块化设计可以系统地调整传感器的特性。在这里,我们展示了如何通过引入非催化活性的小 SmBiT 亚基(DarkBiTs)作为分子内抑制剂来增强这些传感器的灵敏度。从先前开发的生物发光抗体传感器蛋白(LUMABS)开始,我们开发了单组分生物分子开关,其背景信号大大降低,可用于检测三种临床相关的抗体,抗 HIV1-p17、西妥昔单抗(CTX)和 RSV 中和抗体(101F)。这些新的暗 LUMABS 传感器的灵敏度提高了 5-13 倍,从而降低了检测下限。DarkBiTs 作为竞争性分子内抑制剂结构域的使用不仅限于 LUMABS 传感器家族,并且可能用于提高其他基于荧光素酶分割体互补的生物发光传感器蛋白的性能。